Page last updated: 2024-10-26

brl 42810 and Purpura, Thrombotic Thrombocytopenic

brl 42810 has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ryz, K	1
Klassen, J	1
Gough, J	1
Ahmed, SB	1

Other Studies

1 other study available for brl 42810 and Purpura, Thrombotic Thrombocytopenic

Article	Year
Famciclovir and development of thrombotic thrombocytopenic purpura. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2007, Volume: 11, Issue:6 Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Female; Humans; Hypertension, Renal; Middle Aged; Purp	2007